STAMFORD, Connecticut — Jonathan Sackler, one of the owners of OxyContin maker Purdue Pharma, has died, the company confirmed.
Sackler died June 30, according to a court filing. He was 65 and the cause of death was cancer.
He was the son of Raymond Sackler, one the brothers who bought drug company Purdue Frederick in 1952, and served as an executive and board member for the company that was later renamed Purdue Pharma. Like other members of the Sackler family, he has stepped off the board of the company in recent years, though family members retain ownership.
The company is seeking bankruptcy protection as part of an effort to settle nearly 3,000 lawsuits brought against it by state and local governments that blame the company for sparking the opioid crisis that has killed more than 400,000 Americans since 2000. Hundreds of the lawsuits also name family members.
The company’s settlement plan calls for the family, which has been listed among America’s wealthiest, to pay at least $3 billion and give up ownership of Purdue.
Get The Times of Israel's Daily Edition
by email and never miss our top stories
By signing up, you agree to the
terms
Help us report truthfully on social media
As a multimedia journalist, my job is to take the quality, fact-based journalism produced by The Times of Israel newsroom and make it accessible across every platform — from Instagram posts to podcasts to short-form videos.
This is how many, especially young people, consume news these days. But misinformation is rampant on social media. Our team at ToI produces accurate, responsible short-form reporting on Israel and the Jewish world.
If you believe in the importance of factual social media journalism, please consider joining our reader support group, The Times of Israel Community. Your financial support is essential to sustain responsible multimedia reporting.
— Gabriella Jacobs, multimedia journalist
Support our work
Support our work
Already a member? Sign in to stop seeing this
You're a dedicated reader
We’re really pleased that you’ve read X Times of Israel articles in the past month.
That’s why we started the Times of Israel - to provide discerning readers like you with must-read coverage of Israel and the Jewish world.
So now we have a request. Unlike other news outlets, we haven’t put up a paywall. But as the journalism we do is costly, we invite readers for whom The Times of Israel has become important to help support our work by joining The Times of Israel Community.
For as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE, as well as accessing exclusive content available only to Times of Israel Community members.
Thank you,
David Horovitz, Founding Editor of The Times of Israel
Join Our Community
Join Our Community
Already a member? Sign in to stop seeing this
Add ToI as a Preferred Source on Google
